...
首页> 外文期刊>Journal of immunology research. >A Novel Inflammation-Based Prognostic Score: The Fibrinogen/Albumin Ratio Predicts Prognoses of Patients after Curative Resection for Hepatocellular Carcinoma
【24h】

A Novel Inflammation-Based Prognostic Score: The Fibrinogen/Albumin Ratio Predicts Prognoses of Patients after Curative Resection for Hepatocellular Carcinoma

机译:一种新颖的基于炎症的预后评分:纤维蛋白原/白蛋白比可预测肝细胞癌根治性切除术后的患者预后

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background. Inflammation is an important hallmark of cancer. Fibrinogen and albumin are both vital factors in systemic inflammation. This study investigated the prognostic value of the fibrinogen/albumin ratio in HCC patients who underwent curative resection. Methods. HCC patients () who underwent curative resection were evaluated retrospectively. The optimal cutoff value for the fibrinogen/albumin ratio was selected by receiver operating characteristic (ROC) curve analysis. Correlations between preoperative fibrinogen/albumin ratios and clinicopathologic characteristics were analyzed by χ2 test. The area under the receiver operating characteristic curve (AUC) was calculated to compare the prognostic value of the fibrinogen/albumin ratio with other prognostic scores (neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and albumin-bilirubin (ALBI) score). The overall survival (OS) and time to recurrence (TTR) were assessed by the log-rank test and the Cox proportional hazard regression model. Results. An optimal cutoff value of the preoperative fibrinogen/albumin ratio (0.062) was determined for 151 patients who underwent curative resection for HCC via a ROC curve analysis. Fibrinogen/albumin ratio??0.062 was significantly associated with microvascular invasion, an advanced BCLC stage, and ALBI grade. Multivariate analyses revealed that fibrinogen/albumin ratio was an independent predictor for OS () and TTR (). The prognostic ability of fibrinogen/albumin ratio was comparable to other prognostic scores (NLR, PLR, and ALBI score) by AUC analysis. Patients with a fibrinogen/albumin ratio??0.062 had lower 1-, 3-, and 5-year OS rates (66.0%, 41.8%, and 28.2% versus 81.9%, 69.3%, and 56.1%, resp., ) and higher 1-, 3-, and 5-year recurrence rates (60.9%, 79.2%, and 90.5% versus 49.5%, 69.1%, and 77.1%, resp., ) compared with patients with fibrinogen/albumin ratio?≤?0.062. Conclusion. The preoperative fibrinogen/albumin ratio is an effective prognostic factor for HCC patients who underwent curative resection. An elevated fibrinogen/albumin ratio significantly correlates with poorer survival and a higher risk of recurrence in HCC patients.
机译:背景。炎症是癌症的重要标志。纤维蛋白原和白蛋白都是系统性炎症的重要因素。这项研究调查了纤维蛋白原/白蛋白比率在接受根治性切除术的肝癌患者中的预后价值。方法。回顾性评估接受根治性切除术的HCC患者。通过接受者工作特征(ROC)曲线分析选择了纤维蛋白原/白蛋白比的最佳临界值。术前纤维蛋白原/白蛋白比率与临床病理特征之间的相关性通过χ2检验进行了分析。计算接受者工作特征曲线(AUC)下的面积,以比较纤维蛋白原/白蛋白比与其他预后评分(中性粒细胞与淋巴细胞比(NLR),血小板与淋巴细胞比(PLR)和白蛋白-胆红素( ALBI)得分)。通过对数秩检验和Cox比例风险回归模型评估总生存期(OS)和复发时间(TTR)。结果。通过ROC曲线分析确定了151例行根治性肝癌切除术的患者的术前纤维蛋白原/白蛋白比的最佳临界值(0.062)。纤维蛋白原/白蛋白比≥0.062与微血管浸润,晚期BCLC阶段和ALBI等级显着相关。多变量分析显示,纤维蛋白原/白蛋白比是OS()和TTR()的独立预测因子。通过AUC分析,纤维蛋白原/白蛋白比率的预后能力可与其他预后评分(NLR,PLR和ALBI评分)相比。纤维蛋白原/白蛋白比≥> 0.062的患者的1年,3年和5年OS率较低(分别为66.0%,41.8%和28.2%,分别为81.9%,69.3%和56.1%)与具有纤维蛋白原/白蛋白比率的患者相比,一年,三年和五年的复发率更高(分别为60.9%,79.2%和90.5%和49.5%,69.1%和77.1%)。 0.062。结论。术前纤维蛋白原/白蛋白比是接受根治性切除的肝癌患者的有效预后因素。肝纤维化患者中纤维蛋白原/白蛋白比升高与生存率降低和复发风险较高相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号